12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Arcoxia etoricoxib regulatory update

The Scottish Medicines Consortium recommended against the use of Merck's Arcoxia etoricoxib on the National Health Service (NHS) in Scotland for the short-term treatment of moderate pain associated with dental surgery - its approved...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >